Kailera Therapeutics, Inc. Common Stock (KLRA)
PHARMACEUTICAL PREPARATIONS
Kailera Therapeutics, Inc. Common Stock (KLRA) is listed on Nasdaq, where it has traded since April 17, 2026.
- Listed On
- Nasdaq
- Listed Since
- April 17, 2026
- Market Cap
- $1.7B
About Kailera Therapeutics, Inc. Common Stock
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 94 institutions reported holding KLRA, with 116.0 million shares worth $2.6 billion in aggregate. The largest reported holder was Bain Capital Investors, with 26.3 million shares worth $578.4 million. Of the 5 largest holders listed below, all 5 opened new positions in KLRA during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Bain Capital Investors | 26,255,581 | $578M | New position |
| Bain Capital Life Sciences Investors | 22,583,268 | $498M | New position |
| Rtw Investments | 10,776,820 | $237M | New position |
| CPP Investments | 7,304,688 | $161M | New position |
| Atlas Venture Life Science Advisors | 5,171,282 | $114M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is KLRA?
Kailera Therapeutics, Inc. Common Stock (KLRA) is listed on Nasdaq, where it has traded since April 17, 2026.
Who are the largest institutional holders of KLRA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of KLRA were Bain Capital Investors, Bain Capital Life Sciences Investors and Rtw Investments.
How many institutions own KLRA?
94 institutions reported a position in KLRA for the quarter ended June 30, 2026, worth $2.6 billion in total.
Did institutions buy or sell KLRA last quarter?
Of the 5 largest reported holders, all 5 opened new positions in KLRA during the quarter. Every reported holder and its change is on the SentiSense ownership page for KLRA.
Every reported institutional holder, plus insider and congressional trades in KLRA, on SentiSense.